Insider · CIK 0001297500

Pelzer Robert

Reports to the SEC for 2 companies · SOOKE, A1

sec.gov

Transactions

Companies

Filings

CIK

0001297500

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−671 sh	—	—	0
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−970 sh	—	—	0
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−625 sh	—	—	0
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−625 sh	—	—	0
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−750 sh	—	—	0
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.7K sh	—	—	0
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2021-06-08	Sierra Oncology, Inc.Stock Option (Right To Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2020-06-09	Sierra Oncology, Inc.Stock Option (right to buy)A Award	Director	AAward	+16.7K sh	—	—	16,686
2019-06-11	Sierra Oncology, Inc.Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2018-06-12	Sierra Oncology, Inc.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2018-05-07	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2017-06-13	Sierra Oncology, Inc.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2017-05-08	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2016-06-16	Sierra Oncology, Inc.Stock Option (right to buy)A Award	Director	AAward	+38.8K sh	—	—	38,835
2016-05-09	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2015-03-12	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2014-03-06	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,333 sh	—	—	14,843

Recent filings

Accepted (ET)
Jul 14
Pelzer Robert0001209191-22-040266
SEC(opens sec.gov)
Jun 94
Pelzer Robert0001209191-21-039092
SEC(opens sec.gov)
Jun 104
Pelzer Robert0001209191-20-035690
SEC(opens sec.gov)
Jun 124
Pelzer Robert0001209191-19-036491
SEC(opens sec.gov)
Jun 144
Pelzer Robert0001209191-18-037790
SEC(opens sec.gov)
May 94
Pelzer Robert0001209191-18-028983
SEC(opens sec.gov)
Jun 144
Sierra Oncology, Inc.0001209191-17-039878
SEC(opens sec.gov)
May 104
AQUINOX PHARMACEUTICALS, INC0001209191-17-031399
SEC(opens sec.gov)
Jun 204
ProNAi Therapeutics Inc0001209191-16-128854
SEC(opens sec.gov)
May 114
AQUINOX PHARMACEUTICALS, INC0001209191-16-119234
SEC(opens sec.gov)
Mar 164
AQUINOX PHARMACEUTICALS, INC0001209191-15-026574
SEC(opens sec.gov)
Mar 104
AQUINOX PHARMACEUTICALS, INC0001209191-14-018962
SEC(opens sec.gov)

Companies

Address

1272 GILLESPIE ROAD

SOOKE, A1, V9Z 0Z4